Now an all-virtual event
https://awake.net/event/ibogaine-for-the-world-dec-678-2021/
The live event is postponed until September 8-10, 2022
@ Amsterdam’s House of Stories….The Mezrab
Veemkade 576,
1019 BL AMSTERDAM
Monday Dec 6
Jeremy Weate
– A History of Ibogaine
Dana Beal
– Ibogaine 101
Martie Underwood
Exploring the Structure of the Ibogaine State of Consciousness
I will present the findings from my quantitative study conducted in 2020-2021. I used the Phenomenology of Consciousness Inventory, which illuminated key aspects of the structure of consciousness during the ibogaine experience, and also compares the ibogaine experience to other states of consciousness.
+James Rodger
Tobias Erny
– Micro-dose ibogaine for Parkinson’s.
Ibogaine stimulates a sustained increase in Glial cell line-derived neurotrophic factor (GDNF) expression in the brain. GDNF has been shown to increase survival, functioning and sprouting of dopamine neurons in a variety of animal models and human trials. This is particular interesting for the treatment of Parkinson’s Disease (PD). Furthermore, the metabolite of Ibogaine, i.e. Noribogaine acts as a selective serotonin reuptake inhibitor (SSRI) which helps to brighten the mood and counteracts the depressive element of PD. Our pre-clinical observational case report study proofs that Ibogaine alleviates PD symptoms and increases the overall living quality of PD patients.
Dr Eugene Schoenfeld
Recollections of Lamborini
Tuesday Dec 7
Andrea Langlois ICEERS
– sustainable ibogaine panel
+ Georges Oberdeno Essongue
Lakshmi Narayan
– Ibogaine’s Global Challenge
David Subeliani
– Opening clinics in new countries
Anders Beatty
– Pre-care considerations and
Spero Alexio
– Beating the Odds w. Aftercare
Clare Wilkins
– Treating fentanyl , research Chem opioids, the buprenorphine implant
Wednesday Dec. 8
Enrico Fletzer
– The cases of Jan Bastiaans, Howard Lotsof, Sara Glatt & Anwar Jeewa
+ Robbert Jonk
Dr Jeffrey Kamlet
– A review of all fatalities temporally related
Juliana Mulligan
– Ibogaine Today
Rick Doblin
– focus on ibogaine development
Rocky Caravelli
– ibogaine for Meth-amphetamine
+Jasen Chamoun, Australia
+Kimmi del Prado, Philippines
